论文信息 - IDENTIFICATION OF OPTIMAL THERAPEUTIC WINDOW FOR STEROID USE IN SEVERE ALCOHOL-ASSOCIATED HEPATITIS: A WORLDWIDE STUDY. - 字舞流文

IDENTIFICATION OF OPTIMAL THERAPEUTIC WINDOW FOR STEROID USE IN SEVERE ALCOHOL-ASSOCIATED HEPATITIS: A WORLDWIDE STUDY.

Muhammad Tariq Majeed | Douglas A. Simonetto | R. Bataller | M. Poca | P. Kamath | V. Shah | S. Sarin | R. Maiwall | E. Verna | B. Attar | A. Singal | M. Mendizabal | A. Kulkarni | J. Altamirano | J. P. Arancibia | M. Arrese | J. Cabezas | H. Stefanescu | P. Mathurin | D. Simonetto | M. Lucey | Joseph C. Ahn | J. Arab | Won Kim | J. Abraldes | G. Garcia‐Tsao | F. Bessone | T. Issoufaly | P. Rautou | Robert S. Brown | A. Horhat | G. Soriano | M. Higuera-de la Tijera | A. Torre | A. Louvet | E. Alvarado-Tapias | T. Mehta | P. Jalal | L. Díaz | E. Fuentes-López | P. Rao | Pamela Yaquich | J. Roblero | J. Restrepo | M. Ventura-Cots | M. Dirchwolf | Wei Zhang | W. Dunn | F. Cairo | D. Rincón | V. Clark | C. Ramírez | K. Chacko | Natalia Baeza | Roberta C Araújo | L. Skladany | R. Agrawal | Francisco Idalsoaga | R. Parker | D. Morales-Arraez | G. Romero | V. Prado | Seth Buryska | J. Arnold | F. Zamarripa | Berta Cuyàs | Ana Clemente-Sanchez | Tehseen Haider | L. Toro | Zohaib Haque | A. Narvaez | M. Garrido | Víctor Vargas | Andreea Bumbu | Inés García-Carrera | Saba M. Abdulsada | Patricia Guerra Salazar | N. Bystrianska | Marcela de Sousa Coelho | F. Pollarsky | Susana Castro-Sanchez | Maria Laura Garrido | J. Marcelo | Diego Piombino | A. Rojo | J. González | Victor Vargas | Jorge Arnold | R. C. Araújo | Ľ. Skladaný | S. Castro-Sanchez | D. Morales-Arráez | Winston Dunn | F. Idalsoaga | E. Alvarado-Tápias | Eduardo Fuentes-López | Natália Bystrianska

[1] R. Bataller,et al. Are We Really Taking Care of Alcohol‐Related Liver Disease in Latin America? , 2020, Clinical liver disease.

[2] D. Crabb,et al. Diagnosis and Treatment of Alcohol‐Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases , 2020, Hepatology.

[3] G. Casazza,et al. [Glucocorticosteroids for people with alcoholic hepatitis (Cochrane review)]. , 2019, Terapevticheskii arkhiv.

[4] Douglas A. Simonetto,et al. Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH). , 2019, Annals of hepatology.

[5] Dan J Stein,et al. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2018, Lancet.

[6] D. J. Kim,et al. Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled Trials. , 2018, Gastroenterology.

[7] H. Cortez‐Pinto,et al. EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. , 2018, Journal of hepatology.

[8] R. Bataller,et al. Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: Prediction and impact on long‐term survival , 2017, Hepatology.

[9] G. Casazza,et al. Glucocorticosteroids for people with alcoholic hepatitis. , 2019, The Cochrane database of systematic reviews.

[10] S. Atkinson,et al. In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA , 2017, Gastroenterology.

[11] P. Austin. A Tutorial on Multilevel Survival Analysis: Methods, Models and Applications , 2017, International statistical review = Revue internationale de statistique.

[12] R. Bataller,et al. Corticosteroids and occurrence of and mortality from infections in severe alcoholic hepatitis: a meta‐analysis of randomized trials , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[13] Ramon Bataller,et al. Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia. , 2016, Gastroenterology.

[14] M. Murad,et al. Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis. , 2015, Gastroenterology.

[15] D. J. Kim,et al. Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis. , 2015, Gastroenterology.

[16] M. Thursz,et al. Prednisolone or pentoxifylline for alcoholic hepatitis. , 2015, The New England journal of medicine.

[17] Alan D. Lopez,et al. Remembering the forgotten non-communicable diseases , 2014, BMC Medicine.

[18] Peter Cummings,et al. Estimating Adjusted Risk Ratios for Matched and Unmatched Data: An Update , 2011 .

[19] R. Bataller,et al. A New Scoring System for Prognostic Stratification of Patients With Alcoholic Hepatitis , 2008, The American Journal of Gastroenterology.

[20] S. Pol,et al. Influence of liver biopsy on abstinence in alcohol-dependent patients. , 2008, Alcohol and alcoholism.

[21] Alexandre Louvet,et al. The Lille model: A new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids , 2007, Hepatology.

[22] B. Portmann,et al. Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial. , 2006, Journal of hepatology.

[23] L S Murray,et al. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score , 2005, Gut.

[24] W. Kremers,et al. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[25] W. Kim,et al. MELD accurately predicts mortality in patients with alcoholic hepatitis , 2005, Hepatology.

[26] B. Blitzer,et al. Adrenocorticosteroid therapy in alcoholic hepatitis , 1977, The American Journal of Digestive Diseases.

[27] T. Therneau,et al. A model to predict survival in patients with end‐stage liver disease , 2001 .

[28] F. Capron,et al. Excess weight risk factor for alcoholic liver disease , 1997, Hepatology.

[29] E. Christensen,et al. Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables. , 1995, Gut.

[30] T. Hofer,et al. Corticosteroids and alcoholic hepatitis , 1991, Hepatology.

[31] F. Grémy,et al. [Corticoid therapy in the treatment of acute alcoholic hepatitis. Results of a meta-analysis]. , 1991, Gastroenterologie clinique et biologique.

[32] T. Imperiale,et al. Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials. , 1990, Annals of internal medicine.

[33] R. Carithers,et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. , 1989, Annals of internal medicine.

[34] H. Michel,et al. [Treatment of acute alcoholic hepatitis with prednisolone. 45 patients]. , 1987, Presse medicale.

[35] A. Jmelnitzky. [Alcoholic hepatitis: epidemiologic nature and severity of the clinical course in Argentina]. , 1987, Acta gastroenterologica Latinoamericana.

[36] L. Seeff,et al. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. , 1984, The New England journal of medicine.

[37] A. Eddleston,et al. Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis. , 1982, Gut.

[38] M. Omata,et al. Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy , 1980 .

[39] Willis C. Maddrey,et al. Corticosteroid therapy of alcoholic hepatitis. , 1978, Gastroenterology.

[40] F. Iber,et al. A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis. With a note on published results in encephalopathic patients. , 1978, The American journal of gastroenterology.

[41] H. Fallon,et al. Treatment of alcoholic hepatitis with encephalopathy. Comparison of prednisolone with caloric supplements. , 1978, Gastroenterology.

[42] T. Reynolds,et al. Prednisone therapy of acute alcoholic hepatitis. Report of a controlled trial. , 1973 .

[43] P. Christoffersen,et al. Histological changes in human liver biopsies from chronic alcoholics. , 2009, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.

[44] C. Pope,et al. Corticosteroid therapy in severe alcoholic hepatitis. A double-blind drug trial. , 1971, The New England journal of medicine.

[45] H. Fallon,et al. Alcoholic hepatitis. Natural history and evaluation of prednisolone therapy. , 1971, Annals of internal medicine.